Discussing Translation Of Pre-Clinical Models & The Role Of Biomarkers In Clinical Trial Design For Retinal Vascular Diseases

Time: 12:00 pm
day: Day Two


• Understanding the utility and limitations of pre-clinical models of retinal vascular disease

• Discussing the challenges of moving from pre-clinical into the clinic

• Role of biomarkers in evaluating proof of concept efficacy of therapeutics in early-stage trials